Gland Pharma Limited
GLAND
Rangering i aksjer
#3302
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aksjekurs
$32.32
Markedsverdi
$5.33B
Endring (1 dag)
-3.01%
Endring (1 år)
47.99%
Land
IN
Handel Gland Pharma Limited (GLAND)
Kategori
Healthcare
Antall utestående aksjer for Gland Pharma Limited (GLAND)
Antall utestående aksjer per June 2026: 164.83M
Ifølge Gland Pharma Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 164.83M. Ved slutten av March 2024 hadde selskapet 164.74M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Gland Pharma Limited (GLAND) fra 2017 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 164.83M | 0.05% |
| 2025 | 164.75M | 0.00% |
| 2024 | 164.74M | 0.04% |
| 2023 | 164.67M | 0.08% |
| 2022 | 164.54M | 3.96% |
| 2021 | 158.27M | 2.15% |
| 2020 | 154.95M | -0.01% |
| 2019 | 154.96M | 0.01% |
| 2018 | 154.95M | 0.00% |
| 2017 | 154.95M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,355.69% |
IN
|
